Soleno Therapeutics, Inc. (SLNO)

49.67 +0.83 (+1.70%) USD  |  NASDAQ  |  Dec 24, 10:47
More

Soleno Therapeutics SG&A Expense (TTM): 128.55M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for SLNO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 523.36M
AVITA Medical, Inc. 82.72M
Agilon Health, Inc. 238.19M
Geron Corp. 160.96M
Cassava Sciences, Inc. 68.06M